Trial Outcomes & Findings for Consequences of Nocturnal and Daytime Hypoxemia in COPD (NCT NCT00547456)

Last Updated: 2015-12-16

Results Overview

Recruitment status

TERMINATED

Study phase

Target enrollment

20 participants

Primary outcome timeframe

4 weeks

Results posted on

2015-12-16

recruitment details occurred as outlined in protocol

Participant milestones
Measure	Decrease in Oxygen Level When Sleeping Patients are their own controls and tested pre and post the addition of night time supplemental oxygen Oxygen: Oxygen 2-3L Nasal cannula
Overall Study STARTED	20
Overall Study COMPLETED	20
Overall Study NOT COMPLETED	0

Withdrawal data not reported

Consequences of Nocturnal and Daytime Hypoxemia in COPD

Baseline characteristics by cohort
Measure	Decrease in Oxygen Level When Sleeping n=20 Participants Patients are their own controls and tested pre and post the addition of night time supplemental oxygen Oxygen: Oxygen 2-3L Nasal cannula
Region of Enrollment United States	20 participants n=5 Participants
nocturnal hypoxemia	20 participants n=5 Participants
Number of Participants with Nocturnal and Daytime Hypoxemia in COPD	20 participants n=5 Participants
Sex: Female, Male Female	11 Participants n=5 Participants
Sex: Female, Male Male	9 Participants n=5 Participants
Age, Categorical <=18 years	0 Participants n=5 Participants
Age, Categorical Between 18 and 65 years	20 Participants n=5 Participants
Age, Categorical >=65 years	0 Participants n=5 Participants
Age, Continuous	50 years n=5 Participants

Timeframe: 4 weeks

Population: The assay used did not work, as a result, no data for any Outcome Measures was collected. The trial is closed and completed.

Outcome data not reported

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

North Shore LIJ Health System

Phone: 516-465-5400